Surmodics | SRDX - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Abbott USD 10.4B 166M 2025-09
Align Technology USD 1.1B 2.38M 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Artivion USD 103.68M 6.31M 2025-12
Baxter International USD 2.01B 231M 2025-12
Boston Scientific USD 2.83B 13M 2025-09
EDAP TMS EUR 19.02M 498K 2025-09
Edwards Lifesciences USD 892.8M 9.8M 2025-09
Haemonetics USD 195.71M 11.36M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
J&J USD 17.61B 235M 2025-09
Merit Medical Systems USD 223.61M 7.9M 2025-12
Mesa Laboratories USD 40.23M 4.66M 2024-09
Nektar Therapeutics USD 0 2.9M 2024-09
Option Care Health USD 473.57M 934K 2025-12
Stryker USD 4.04B 396M 2025-12
Surmodics USD 23.27M 790K 2024-09
Trinity Biotech USD 15.02M 3.7M 2025-09